Literature DB >> 7979656

Long-term results in surgically managed esophageal achalasia.

R A Malthaner1, T R Tood, L Miller, F G Pearson.   

Abstract

The long-term clinical results of surgical treatment for esophageal achalasia were reviewed in 35 patients having a minimum follow-up of 10 years. Group A (n = 22) are those patients whose first procedure (myotomy and Belsey partial fundoplication) was done at our hospital. Group B (n = 13) are those who had undergone one or more previous operations elsewhere. In group A good to excellent results occurred in 21/22 patients (95%) at 1 year, 17/22 (77%) at 5 years, 15/22 (68%) at 10 years, 11/16 (69%) at 15 years, and 6/9 (67%) at 20 or more years. Two patients underwent early reoperation (2 and 5 years) for dysphagia due to incomplete myotomy. Three patients underwent esophagectomy (7, 19, and 23 years) and one patient underwent an antrectomy and Roux-en-Y diversion (23 years) for late-onset complications of reflux. Three of 13 group B patients had had multiple prior operations and had severe reflux damage at presentation and underwent immediate esophagectomy. Ten patients had one or more conservative operations in our hospital, and 4 of these eventually required esophagectomy for disabling reflux. Therefore, there were 10 patients (groups A+B) who underwent esophageal resection, all but 1 of whom had endoscopically documented reflux and 5 of whom had peptic strictures. Six of the 10 esophagectomies were performed more than 10 years (13 to 23 years) after the first operation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7979656     DOI: 10.1016/0003-4975(94)91910-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  22 in total

Review 1.  Surgery for achalasia: 1998.

Authors:  Y Shiino; C J Filipi; Z T Awad; T Tomonaga; R E Marsh
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 2.  An antireflux procedure is critical to the long-term outcome of esophageal myotomy for achalasia.

Authors:  J H Peters
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

3.  Objective analysis of gastroesophageal reflux after laparoscopic heller myotomy: an anti-reflux procedure is required.

Authors:  S E Burpee; J Mamazza; C M Schlachta; Y Bendavid; L Klein; H Moloo; E C Poulin
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

4.  The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up.

Authors:  M Costantini; G Zaninotto; E Guirroli; C Rizzetto; G Portale; A Ruol; L Nicoletti; E Ancona
Journal:  Surg Endosc       Date:  2005-01-10       Impact factor: 4.584

5.  Long-term results of conventional myotomy in patients with achalasia: a prospective 20-year analysis.

Authors:  Ines Gockel; Theodor Junginger; Volker F Eckardt
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

6.  Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months.

Authors:  Attila Csendes; Italo Braghetto; Patricio Burdiles; Owen Korn; Paula Csendes; Ana Henríquez
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

7.  Esophagectomy for end stage achalasia.

Authors:  Stephen M Glatz; J David Richardson
Journal:  J Gastrointest Surg       Date:  2007-07-11       Impact factor: 3.452

8.  Laparoscopic Heller myotomy as the gold standard for treatment of achalasia.

Authors:  Peter Nau; David Rattner
Journal:  J Gastrointest Surg       Date:  2014-09-10       Impact factor: 3.452

9.  Video-assisted thoracoscopic esophagomyotomy for achalasia after pulmonary lobectomy.

Authors:  K Mikami; K Kawahara; R Maruyama; H Ueda; T Shirakusa; A Motohiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-11

10.  The cost-effectiveness of treatment strategies for achalasia.

Authors:  J Barry O'Connor; Mendel E Singer; Thomas F Imperiale; Michael F Vaezi; Joel E Richter
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.